Recigen®
Bortezomib
3,5 mg
ORIONZOMIB is for adults with multiple myeloma who had treatment before and can’t or won’t have a stem cell transplant.
ORIONZOMIB with other drugs helps adults with new multiple myeloma who can’t have strong chemo or transplant.
ORIONZOMIB with steroids (and sometimes thalidomide) is for new multiple myeloma patients who can have strong chemo and transplant.
ORIONZOMIB with other drugs is for adults with new mantle cell lymphoma who can’t have a stem cell transplant.